Trillium Asset Management LLC Purchases 2,858 Shares of CVS Health Corporation (CVS)
Trillium Asset Management LLC boosted its position in CVS Health Corporation (NYSE:CVS) by 1.6% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 178,663 shares of the pharmacy operator’s stock after buying an additional 2,858 shares during the period. Trillium Asset Management LLC’s holdings in CVS Health Corporation were worth $14,375,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Gemmer Asset Management LLC boosted its position in CVS Health Corporation by 15.3% in the second quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock valued at $121,000 after buying an additional 200 shares during the last quarter. TB Alternative Assets Ltd. purchased a new stake in CVS Health Corporation in the second quarter valued at approximately $121,000. SRS Capital Advisors Inc. boosted its position in CVS Health Corporation by 48.2% in the first quarter. SRS Capital Advisors Inc. now owns 2,256 shares of the pharmacy operator’s stock valued at $177,000 after buying an additional 734 shares during the last quarter. Grace & White Inc. NY purchased a new stake in CVS Health Corporation in the second quarter valued at approximately $199,000. Finally, Nadler Financial Group Inc. purchased a new stake in CVS Health Corporation in the second quarter valued at approximately $202,000. Hedge funds and other institutional investors own 81.46% of the company’s stock.
CVS Health Corporation (NYSE:CVS) opened at 76.49 on Friday. The firm has a market capitalization of $77.76 billion, a P/E ratio of 15.24 and a beta of 0.92. CVS Health Corporation has a 1-year low of $69.30 and a 1-year high of $88.84. The company has a 50-day moving average price of $78.86 and a 200 day moving average price of $78.71.
CVS Health Corporation (NYSE:CVS) last posted its earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 EPS for the quarter, topping the Zacks’ consensus estimate of $1.31 by $0.02. The company had revenue of $45.69 billion for the quarter, compared to the consensus estimate of $45.36 billion. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. CVS Health Corporation’s quarterly revenue was up 4.5% compared to the same quarter last year. During the same period in the previous year, the business earned $1.32 earnings per share. Analysts expect that CVS Health Corporation will post $5.88 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, November 3rd. Shareholders of record on Tuesday, October 24th will be given a dividend of $0.50 per share. The ex-dividend date is Monday, October 23rd. This represents a $2.00 dividend on an annualized basis and a yield of 2.61%. CVS Health Corporation’s payout ratio is 39.92%.
In other CVS Health Corporation news, EVP Thomas M. Moriarty sold 20,547 shares of the business’s stock in a transaction on Monday, October 2nd. The stock was sold at an average price of $81.17, for a total transaction of $1,667,799.99. Following the sale, the executive vice president now directly owns 43,178 shares in the company, valued at $3,504,758.26. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, COO Jonathan C. Roberts sold 85,743 shares of the business’s stock in a transaction on Monday, September 18th. The stock was sold at an average price of $83.14, for a total value of $7,128,673.02. Following the sale, the chief operating officer now owns 119,555 shares in the company, valued at $9,939,802.70. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 716,625 shares of company stock worth $58,318,431. 0.61% of the stock is owned by company insiders.
A number of equities research analysts recently commented on the company. Jefferies Group LLC set a $86.00 target price on CVS Health Corporation and gave the company a “hold” rating in a research report on Wednesday. BidaskClub upgraded CVS Health Corporation from a “sell” rating to a “hold” rating in a research report on Wednesday, August 2nd. Needham & Company LLC reiterated a “hold” rating on shares of CVS Health Corporation in a research report on Thursday, October 12th. Citigroup Inc. dropped their target price on CVS Health Corporation from $88.00 to $87.00 and set a “neutral” rating on the stock in a research report on Thursday, August 17th. Finally, SunTrust Banks, Inc. set a $85.00 target price on CVS Health Corporation and gave the company a “buy” rating in a research report on Thursday, October 12th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and sixteen have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of $89.68.
About CVS Health Corporation
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.